Literature DB >> 28068048

Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2018; Amendments to Special Enrollment Periods and the Consumer Operated and Oriented Plan Program. Final rule.

.   

Abstract

This final rule sets forth payment parameters and provisions related to the risk adjustment program; cost-sharing parameters and cost-sharing reductions; and user fees for Federally-facilitated Exchanges and State-based Exchanges on the Federal platform. It also provides additional guidance relating to standardized options; qualified health plans; consumer assistance tools; network adequacy; the Small Business Health Options Programs; stand-alone dental plans; fair health insurance premiums; guaranteed availability and guaranteed renewability; the medical loss ratio program; eligibility and enrollment; appeals; consumer-operated and oriented plans; special enrollment periods; and other related topics.

Entities:  

Mesh:

Year:  2016        PMID: 28068048

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.

Authors:  Rudy S Suidan; Weiguo He; Charlotte C Sun; Hui Zhao; Nicole D Fleming; Pedro T Ramirez; Pamela T Soliman; Shannon N Westin; Karen H Lu; Sharon H Giordano; Larissa A Meyer
Journal:  Gynecol Oncol       Date:  2017-01-26       Impact factor: 5.482

2.  Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia.

Authors:  David Campbell; Marlo Blazer; Lisa Bloudek; John Brokars; Dinara Makenbaeva
Journal:  Am Health Drug Benefits       Date:  2019-11

3.  Patients' Knowledge and Attitude toward the Disposal of Medications.

Authors:  Aeshah AlAzmi; Hani AlHamdan; Rayf Abualezz; Faiz Bahadig; Noha Abonofal; Mohamed Osman
Journal:  J Pharm (Cairo)       Date:  2017-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.